Dextromethorphan Hydrobromide

氢溴酸右美沙芬

Report date: 2026/03/23 20:03:44

Base Information

Drug NameDextromethorphan Hydrobromide
Drug Alias NameTussycalmSucretsCodotussylRo-1-5470/5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsVasomotor symptomMenopausal symptomsSchizophrenia +[17] 
Global Approved IndicationsCough
Approved Indications in ChinaCough
Original Approved Country/TerritoryJapan
Original Approved Date1955/10/01
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTeva Canada LtdThornton & Ross LtdJohns Hopkins University +[7] 
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgDuke UniversityNational Institute Of Dental And Craniofacial Research (Nidcr) +[9] 
Active IndicationsVasomotor symptomMenopausal symptomsDepressive Disorder, Treatment-Resistant +[6] 
Inactive IndicationsSchizophreniaAutism Spectrum DisorderNeuralgia +[11] 

Other Information

ATC CodeR05DA09
Related LinksWikipediaDrugBankKEGG